Segment Information (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Summary of financial information concerning the entity's reportable segments

	Three Months Ended March 31, 2020
	Reporting Segment				Corporate and Other
(in thousands)	Healthcare		Research					Consolidated
Revenue	$	95,707	$	13,820	$	3,504		$	113,031
Gross profit	64,424		5,675		409			70,508
Income/(loss) before income taxes	29,876		2,043		(19,586		)	12,333
Depreciation and amortization	8,435		1,066		984			10,485
Capital expenditures	6,211		391		382			6,984

	Three Months Ended March 31, 2019
	Reporting Segment				Corporate and Other
(in thousands)	Healthcare		Research					Consolidated
Revenue	$	88,009	$	12,964	$	3,006		$	103,979
Gross profit	59,864		4,334		580			64,778
Income/(loss) before income taxes	29,608		764		(20,760		)	9,612
Depreciation and amortization	8,291		928		802			10,021
Capital expenditures	4,442		482		410			5,334